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Background. Transfusion of blood components continues to be an important therapeutic 
resource into the 21st century. Between 5 and 58% of transfusions carried out are estimated to be 
unnecessary. According to several studies, at least 20% of packed red blood cell transfusions (RBCT) 
are administered in hospital emergency departments (ED), but few data are available about the 
appropriateness of RBCT in this setting. This multicentre, cross-sectional observational study aims 
to assess the appropriateness of RBCT indications and transfused volumes in patients who attend ED. 
Materials and methods. The study cohort is made up of consecutive consenting adult patients 
(≥18 years old) who received RBCT in ED over a 3-month period and for whom relevant clinical 
data were collected and analysed.
Results. Data from 908 RBCT episodes (2±1 units per transfused patient) were analysed. RBCT 
was considered appropriate in 21.4% (n=195), with significant differences according to RBCT 
indication (p<0.001), hospital level (p<0.001) and prescribing physician (p=0.002). Pre-transfusion 
haemoglobin level (Hb) negatively correlated with RBCT appropriateness (r=–0.616; p<0.01). Only 
72.4% of appropriate RBCT had a post-transfusion Hb assessment (n=516). Of these, 45% were 
considered to be over-transfused (n=232), with significant differences according to RBCT indication 
(p=0.012) and prescribing physician (p=0.047). Overall, 584/1,433 (41%) of evaluable RBC units 
were unnecessarily transfused.
Discussion. The appropriateness of RBCT in ED is similar to other hospital departments, but the 
rate of over-transfusion was high. These data support the need for a reassessment after transfusion 
of each RBC unit before further units are prescribed. In view of these results, we recommend that 
physicians should be made more aware of the need to prescribe RBCT appropriately in order to 
reduce over-transfusion.
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Introduction
Transfusion of blood components (TBC) continues 
to be an important therapeutic resource into the 
21st century. Thanks to advances in science and the 
implementation of legal regulations, in recent years, 
TBC has achieved reasona bly high levels of safety1-5. 
Such progress has meant that Transfusion Medicine 
is now an established area of medical specialisation 
made up of a multidisciplinary team of health-
care professionals6. The establishment of Hospital 
Transfusion Committees has also led to improvements 
in the quality of clinical care through promoting 
audits, educational programs, the development of 
guidelines, and the implementation of cost-saving 
strategies7.
However, despite such advances, there are still 
significant potential risks involved in TBC. The safety 
of the transfusion lies not only in the correct selection, 
preparation and administration of blood products, 
but also in the ability to correctly interpret when 
such intervention is appropriate. It is estimated that 
between 5 and 58% of transfusions are unnecessary6-10. 
Administration should always be performed by 
medical prescription, and, whenever possible, a signed 
informed consent should be obtained from the patient. 
An indication for TBC is generally based on clinical 
practice guidelines or consensus recommendations 
from expert panels, but is rarely supported by clinical 
trials11-13. In this context, TBC is a complex intervention 
which must be based on clinical evidence and adjusted 
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according to cardiovascular risk factors and laboratory 
test results. It is essential to rationalise and optimise 
TBC prescription since blood is a limited therapeutic 
resource, which depends exclusively on the altruism of 
individual donors2.
Over 50% of all TBCs are given to surgical or 
critically ill patients. Red blood cell transfusion (RBCT) 
is the most frequently used and anaesthesiologists 
are responsible for about 50% of these6,14,15. In recent 
years, there has been an increase in the use of TBC in 
Emergency Departments (ED) when compared to other 
hospital areas. In Spain, several studies have assessed the 
epidemiology and adequacy of the indication of TBC in 
different hospital areas, but the incidence of inadequate 
TBC indications in the ED is still unknown16-20. However, 
it is expected to be higher than in other departments 
because decisions related to treatment must be taken 
much quicker in ED than in other hospital areas, and 
this could contribute to some laxity in the application 
of established TBC criteria.
This multicentre study was aimed at assessing the 
appropriateness of RBCT prescriptions and transfused 
volumes in ED. Secondary study variables were the 
appropriateness of RBCT according to indication, hospital 
and level of expertise of the prescribing physician.
Materials and methods
Study design
This was a multicentre, cross-sectional observational 
study. The study cohort was made up of consecutive 
consenting adult patients (≥18 years old) who received 
RBCT in ED of any of 5 participating centres (Hospitals 
A to E) over a 3-month period. A transfusion episode was 
defined as the interval between the prescription of an RBCT 
and completion of its administration. When several RBC 
units were administered to the same patient under the same 
condition (e.g. acute haemorrhage), all the units received 
are considered to be part of a single transfusion episode.
Spanish public health hospitals are classified 
according to a cluster analysis of the National Health 
System, as follows21.
- Group V: very large hospitals covering many square 
metres that offer a wide range of care for a large 
number of patients, in a large structure with extensive 
care services; over 1,000 beds; more than 500 
doctors, and an average 300 resident physicians in 36 
different specialties (minimum 17). Technologically 
very advanced, with a broad portfolio of complex 
services (>5 complex services), these hospitals 
receive more than 200,000 emergency cases per year.
- Group IV: includes large hospitals, with 500-1,000 
beds, and 200-900 staff physicians. With an average 
of 4 complex services, they are characterised by 
having at least 25 accredited residency programmes 
(mean 30) and over 100 resident physicians. These 
hospitals receive approximately 150,000 emergency 
cases per year.
- Group III: medium-sized hospitals, with around 500 
beds (although there is considerable variability), around 
100-500 staff physicians, and 160 resident physicians.
- Group II: have fewer than 500 beds, reduced teaching 
capacity (although some have up to 8 different 
specialties; 2 complex services at most) and deal 
with less than 100,000 emergency cases per year.
- Group I: small community hospitals with on average 
less than 150 beds, with little provision of high-tech 
equipment or facilities, few doctors, that do not treat 
more complex cases. 
Among participating hospitals, A and B belong to 
Group V, C was assigned to Group IV, and D and E 
belong to Group II. 
Data collection 
A Microsoft Office Excel® (Redmond, WA, USA)
database was set-up for each centre using data provided 
by Blood Banks (Transfusion Services) for transfusion 
episodes that occurred during the study period. 
Additional data from patients receiving RBCT at the 
ED during the study period were collected from hospital 
information systems (electronic medical records, 
laboratories, electronic prescription systems) and were 
up-loaded to complete the database. Subsequently, 
databases of all the hospitals were merged and exported 
to SPSS 22.0® (IBM SPSS Statistics v.22.0, Chicago, 
IL, USA) for further analysis.
End-point variables 
The primary end point was the "appropriateness" 
of the RBCT prescription and transfused volume. 
Appropriateness of RCBT was evaluated according to 
pre-transfusion haemoglobin (Hb) levels and patients' 
characteristics, according to the Spanish Society of Blood 
Transfusion Guidelines 2010 (Table I)1. Two members 
of the research team (a Clinical Pharmacologist and a 
Pharmacist) defined appropriateness. Any discrepancies 
were then discussed with a third member of the research 
team (a Haematologist) until a consensus was reached. 
To evaluate the "appropriateness" of RCBT volume, 
as estimated by post-transfusion Hb according to the 
Seville Consensus Document Update 201311, we defined 
over-transfusion as occurring when the post-transfusion 
Hb level was more than 2 g/dL above the relevant 
Hb transfusion threshold for each particular RBCT 
indication (Table I). The RBCT index is the median 
(interquartile range) number of RBC units per transfused 
patient. The number of RBC units over-transfused was 
estimated as the sum of the differences between actual 
post-transfusion Hb and the target post-transfusion Hb 
for each transfusion episode, assuming that one RBC 
unit increased Hb level by 1 g/dL22. 
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The "appropriateness" of the RBCT prescription and 
transfused volume, according to indication, hospital level 
and prescribing physician, were secondary study variables. 
Indications for RBCT were divided into acute anaemia, 
chronic anaemia, low Hb level, and reason for transfusion 
not registered. Physicians prescribing RBCT at the ED 
were classified as follows: ED consultant (EDC), resident 
physicians of any specialty who work shifts at ED (MDR), 
consultant not belonging to the ED (NEDC) who request 
transfusion at ED, or "unknown" physician. 
Statistical analyses 
Qualitative variables were summarised by their 
frequency distribution as well as quantitative variables 
by their mean and standard deviation (±SD) or median 
(interquartile range). The Kolmogorov-Smirnov test 
was used to prove Gaussian distribution. In case of 
qualitative variables, comparison was evaluated by the 
χ2 test. For continuous normally distributed variables, 
the Student's t-test was used to compare two groups. 
The Mann-Whitney U test was used for continuous 
not normally distributed variables. Correlations were 
assessed with the Pearson's r coefficient. Null hypothesis 
was rejected by a type I error less than 0.05 (p<0.05). 
Results
Overall, data from 1,098 RBCT episodes at the ED 
were collected. Those transfusion episodes performed 
for any surgical or gynaecological reason, involving 
no RBCT or without a pre-transfusion Hb level, were 
excluded; this left 908 transfusion episodes that went 
forward for analysis (Figure 1). Transfused patients 
(55.6% men; mean age 72.6±15.7 years) received 2 
(interquartile range 1-2) packed RBC units. Underlying 
pathologies in patients receiving RBCT were haemato-
oncological diseases (24%), bleeding due to antiplatelet 
(20%) or anticoagulation (20%) therapy, chronic kidney 
disease (15%), chronic heart failure (13%), and chronic 
liver disease (8%). Mean pre-transfusion Hb was 7.7±1.8 g/
dL, and mean post-transfusion Hb 9.5±1.6 g/dL. Patients 
remained at the ED an average of 1.1±2.6 days.
Patients were divided into four groups according to 
the RBCT indication: acute anaemia (63.9%), chronic 
anaemia (10.7%), low Hb level (16.8%), and reason 
for transfusion not registered (8.6%). Prescription of 
RBCT was found inappropriate in 21.4% of all the 
episodes. Distribution of RBCT episodes according to 
pre-transfusion Hb is shown in Figure 2. Appropriateness 
of RBTC for patients with pre-transfusion Hb less than 7 
g/dL was 100%, 95% for pre-transfusion Hb 7-7.9 g/dL, 
71% for pre-transfusion Hb 8.0-8.9 g/dL, and only 21% 
for RBCT with pre-transfusion Hb 9 g/dL or more, a 
cut-off point at which clinical characteristics should be 
carefully evaluated before making a decision about RBCT 
(Figure 2). Pre-transfusion Hb negatively correlated with 
RBCT appropriateness (p<0.001). As shown in Figure 3, 
78.6% (713/908) of RBCT prescriptions were considered 
appropriate, with significant differences observed 
according to RBCT indication (p<0.001), hospital level 
(p<0.001), and prescribing physician (p=0.002). RBCT 
index was 2 (1-2) (1,388 RBC units) and 2 (1-2) (366 
RBC units), for appropriate and inappropriate RBCT, 
respectively (p=0.436).
We then evaluated the appropriateness of RBCT 
volume, as estimated by post-transfusion Hb level, 
for those episodes that had adequate transfusion 
indication. Only 72.4% (516/713) of appropriate RBCT 
episodes (1,067 RBC units) have a post-transfusion Hb 
control (Figure 1). Of these, 45% (232/516) received 
an inappropriate RBCT volume (over-transfusion), 
with differences according to indication (p=0.012) or 
prescribing physician (p=0.047) (Figure 4). In addition, 
all RBCT episodes without an appropriate indication 
(197/908, 21.5%) (Figure 1) were also considered to 
be an over-transfusion. Thus, over-transfusion was 
estimated to occur in 60% of RBCT episodes analysed 
for this variable (n=711), resulting in 584 RBC units 
unnecessarily transfused (584/1,433, 41%).
Discussion
Blood components are a scarce resource and their use 
should, therefore, be limited to specific indications. Several 
scientific associations have developed clinical practice 
guidelines, issuing recommendations to reduce unnecessary 
transfusions and optimise the use of donated units1,11,13. 
Although in recent years these clinical guidelines have 
been made widely available, this does not necessarily mean 
that their recommendations are followed. Nevertheless, a 
progressive improvement in the appropriateness of TBC 
indication has been seen over the years. 
Table I - Recommendations of the guide to the transfusion of blood components and plasma derivatives of the Spanish Society 
of Blood Transfusion and Cell Therapy.
Hb (g/dL) Clinical situation
Acute anaemia <7 Any clinical situation.
7-8.9 Haemodynamically unstable or associated risk factors: coronary heart disease, heart failure, cerebrovascular 
disease, myocardial infarction.
≥9 Difficult to control haemorrhage/signs and symptoms of anaemia.
Chronic anaemia <8 Signs and symptoms of anaemia and/or associated risk factors.
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Figure 2  - Distribution of transfusion episodes in the Emergency Department, 
according to pre-transfusion haemoglobin levels (g/dL). 
 Appropriateness of the transfusion indication was assessed according 
to the transfusion criteria shown in Table I. (%): percentage of 
appropriate transfusion for each pre-transfusion haemoglobin level; 
Hb: haemoglobin; r: Pearson's correlation coefficient. 
Figure 1 - Transfusion episodes in the Emergency Department.
 RBC: red blood cell; Hb: haemoglobin.
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Figure 3 - Appropriateness of RBC transfusion indication at the Emergency Department, 
according to criteria depicted in Table I, according to underlying cause, hospital 
level and prescribing physician (n=908). 
 EDC: Emergency Department consultant; MDR: resident physicians of any specialty 
who perform shifts at Emergency Department; NEDC: consultant not belonging 
to the ED; Unknown: unknown physician.
Figure 4 - Appropriateness of RBC transfusion volume at the Emergency Department, 
as reflected by post-transfusion haemoglobin in patients with a correct 
indication for transfusion, according to criteria depicted in Table I, according 
to underlying cause, hospital level and prescribing physician (n=516).
 EDC: Emergency Department consultant; MDR: resident physician of any specialty 
who perform shifts at Emergency Department; NEDC: consultant not belonging 
to the ED; Unknown: unknown physician. 
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A 1997 study evaluated the appropriateness of 
RBCT in the ED of a Spanish hospital, and found 
that 44% were appropriate and 40% inappropriate, 
whereas appropriateness could not be established in 
16% transfusion episodes23. Compared to these results, 
our analysis showed a significant improvement in the 
appropriateness of RBCT, which might reflect the 
gradual influence of clinical transfusion guidelines on 
physician's decision-making, as well as the concerns 
of hospital managers regarding the consequences of an 
inappropriate use of RBCT24.
In this context, a study evaluating the appropriateness 
of transfusion practice at a hospital in Northern Ireland 
during 2005 observed that 23% of RBCT transfusions 
were considered inappropriate22, whereas a French 
study provided evidence that only 7% of RBCT were 
not in accordance with recommendations of national 
protocols for transfusion25. A study investigating the 
impact of three national blood transfusion indicators 
(specifically designed for critical care) on appropriate 
blood transfusion indications found 13% of RBCT 
were given off protocol, whereas appropriateness of 
platelet concentrate transfusion (36-52%) and fresh-
frozen plasma administration (26%) was much lower20. 
Interestingly, in the Northern Ireland study, it was also 
observed that 19% of patients were over-transfused22.
When assessing whether or not RBCT has been used 
appropriately, consideration should be given not only 
to the "patient's need for transfusion", but also to "how 
many units" were transfused. Besides being a waste of 
resources, the Serious Hazards of Transfusion (SHOT) 
reports have indicated that over-transfusion is dangerous; 
e.g. a single unit of RBCT is strongly recommended in 
some populations of haemodynamically stable, non-
bleeding patients to avoid "transfusion-associated 
cardiac overload"26. Compared with a liberal transfusion 
strategy, a restrictive strategy significantly reduced the 
number of RBCT (1.5±2.3 vs 3.7±3.8 units/patient) 
and improved outcomes in patients with acute upper 
gastrointestinal bleeding27. In critical and surgical 
patients, it has been recently shown that transfusion of 
a single unit of RBCT increased the multivariate risk of 
mortality, wound problems, pulmonary complications, 
post-operative renal dysfunction, systemic sepsis, 
composite morbidity, and length of hospital stay 
compared to propensity-matched patients who did not 
receive RBCT28,29. There was also a dose-dependent 
increase in the risk of a poorer outcome29. 
However, a few studies have examined this aspect of 
RBCT, reporting over-transfusion rates between 19 and 
75%22,30,31. The need, therefore, for a post-transfusion 
Hb target has been recognised11. Consistent with other 
research22, our study found that post-transfusion Hb 
remained around 9.5 g/dL, regardless of pre-transfusion Hb, 
resulting in high rates of over-transfusion. In daily practice, 
rates of adherence to the traditional goal of post-transfusion 
Hb of 10 g/dL, which is mostly based on the physician's 
routine approach and not according to patient need, might 
still be behind those of over-transfusion events32. 
Although not the focus of this research, we can 
speculate that the inappropriate requests for RBCT 
could be due to: a) lack of adherence of physicians to 
transfusion protocols; b) a lack of the strict supervision 
required by the Transfusion Service (Blood Bank) staff to 
limit the number of RBC units requested; c) incomplete 
RBC request forms; and d) a lack of awareness of the 
risks and unnecessary costs of the indiscriminate use 
of blood products. In Spain, most physicians have very 
low awareness of the real socio-economic cost burden 
of TBC. In this regard, at the Pennine Acute Trust (UK), 
it has been estimated that if anaemic patients with ID 
were stabilised with one RBC unit and then backed 
with IV iron infusion, there would be a 4.5% reduction 
in the number of RBC units transfused each year, with 
a potential total cost saving of about 60,000 Euro/
year33. Data from a recently published study support 
the feasibility of a clinical protocol for management of 
sub-acute anaemia at the ED, and the efficacy, safety 
and tolerability of IV iron in this setting34. 
Several studies have suggested the need for greater 
control over the use of blood products, of underlining the 
importance of the Transfusion Service's staff reviewing 
the indications for TBC, and of establishing hospital 
transfusion committees35,36. Adherence to transfusion 
indicators has been shown to play a key role in reducing 
the variability in transfusion practice (especially for 
RBCT), the percentage of patients transfused, the volume 
of transfused components, and transfusion-associated 
complications (e.g. nosocomial infection)20,37,38.
Our study may have been limited by its observational 
design, e.g. data collection was not uniform across all 
the participating hospitals. Some medical records did 
not provide full information about the reasons for 
transfusion and/or information about the transfusion 
procedure itself, which limits data collection and 
analysis. However, this circumstance is not unique 
to our study but is a common characteristic in 
multicentre observational studies. Audet et al. found 
significant limitations in a retrospective analysis 
of the appropriateness of RBCT due to insufficient 
documentation of transfusion episodes39. A national 
survey conducted in Brazil mentioned that Hb values 
were not recorded before RBCT40 and, again in 
Brazil, de Sousa et al. found that 14% of RBCT had 
an adequate indication, and 8.9% were inappropriate; 
but the most relevant finding was that appropriateness 
was classified as inconclusive in 74.6% of RBCT 
because of the lack of information about the transfusion 
requests41. Likewise, after reviewing medical records, 
Friedman et al. observed a positive correlation 
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between inadequate physician documentation of 
RBCT and inappropriateness of RBCT, as measured by 
disagreement with the hospital transfusion protocol42. 
Conclusions
In conclusion, our data suggest that appropriateness 
of RBCT in ED is similar to that in other hospital 
departments, and reinforce the need to reassess the patient 
after transfusion of each RBCT unit before prescribing 
additional ones. In view of these results, we recommend 
the implementation of educational interventions aimed 
at the staff responsible for prescribing RBCT in order 
to increase the number of appropriate indications and to 
reduce the rate of over-transfusion in the ED.
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